IDiyas

For the Inventor, By the Inventor

Tokyo, Japan

Ryushi Seo

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 7.8

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Tsukuba, JP (2007)
  • Chuo-ku, JP (2009)
  • Tokyo, JP (2011 - 2024)

Company Filing History:

goldMedal16 out of 416 
 
Astellas Pharma Gmbh
 patents
silverMedal1 out of 20 
 
Mitobridge, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2007-2024

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):
1. 11912679 - Aryl alkynamide derivatives (2024-02-27),
2. 8901126 - Substituted imidazo[1,5-A]quinoxalin-4-ones are useful for preventing or treating storage dysfunction, voiding dysfunction and bladder/urethral diseases (2014-12-02),
3. 8822448 - Pyrazoloquinoline compound (2014-09-02),
4. 8815920 - Substituted amide compound (2014-08-26),
5. 8674096 - Substituted imidazo[1,5-a]quinoxalin-4-ones as phosphodiesterase 9 inhibitors (2014-03-18),
6. 8669246 - Substituted amide compound (2014-03-11),
7. 8598355 - Amide compound (2013-12-03),
8. 8357688 - Substituted imidazo[1,5-a]quinoxalin-4(5H)-ones as PDE9 inhibitors (2013-01-22),
9. 8304547 - Azolecarboxamide compound or salt thereof (2012-11-06),
10. 8222274 - Pyrrole derivative or salt thereof (2012-07-17),
11. 8163746 - Azolecarboxamide derivative (2012-04-24),
12. 8153658 - Piperidine derivative or salt thereof (2012-04-10),
13. 8030489 - Ornithine derivative (2011-10-04),
14. 7985764 - Amide derivative or salt thereof (2011-07-26),
15. 7585886 - Pyrrolidine derivative or salt thereof (2009-09-08),

Title: **Ryushi Seo: Innovator in Pharmaceutical Compounds**

Introduction

Ryushi Seo is a prominent inventor based in Tokyo, Japan, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 16 patents, Seo has been pivotal in developing compounds that target critical health challenges, particularly those related to autoimmune and neurodegenerative diseases.

Latest Patents

Seo's latest innovations include groundbreaking work on aryl alkynamide derivatives. These compounds show a promising inhibitory action on STING, presenting potential treatment avenues for various STING-mediated diseases such as autoimmune diseases and neurodegenerative disorders. Another notable invention is focused on substituted imidazo[1,5-A]quinoxalin-4-ones, which have demonstrated effectiveness in preventing and treating storage dysfunction, voiding dysfunction, and bladder/urethral diseases through their PDE9-inhibitory action.

Career Highlights

Throughout his career, Ryushi Seo has aligned with leading pharmaceutical companies, including Astellas Pharma GmbH and Mitobridge, Inc. His work in these organizations has been instrumental in advancing medical treatments and therapeutic strategies, leveraging his patent portfolio to address unmet medical needs within the community.

Collaborations

Seo has collaborated with talented professionals, including Hiroyuki Kaizawa and Hidenori Azami. Working alongside these colleagues, he has fostered innovative research that enhances the quality of life for patients suffering from various health conditions.

Conclusion

With a standout career and multiple patents to his name, Ryushi Seo embodies the spirit of innovation in the pharmaceutical industry. His contributions not only advance scientific knowledge but also pave the way for new therapeutic options, marking him as a significant figure in the realm of medical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…